Titan SGS stapler results in shorter length of hospital stay, fewer readmissions, reduced post-operative nausea/vomiting events and operative times
Tirzepatide reduced the risk of developing T2Dm by 94% in adults with pre-diabetes and obesity or overweight
Strong relationship between the increase in metabolic activity caused by once-daily GLP-1 and the amount of weight lost
Australian bariatric procedures fall to lowest rate since 2016
Journal watch 21/08/2024
FDA expands Ethicon’s Linx Reflux Management System to include patients with Barrett’s esophagus experiencing GERD
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module III)
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module I)
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module II)
GLP-1 RAs alone are not enough for individuals to achieve health goals
